BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 19388212)

  • 1. Extracorporeal methoxsalen: new drug. Cutaneous T cell lymphoma: for rare patients, but better assessment needed.
    Prescrire Int; 2009 Feb; 18(99):16. PubMed ID: 19388212
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma and buffy coat concentration of 8-methoxypsoralen in patients treated with extracorporeal photopheresis.
    Balogh A; Merkel U; Looks A; Vollandt R; Wollina U
    Exp Toxicol Pathol; 1998 Sep; 50(4-6):397-401. PubMed ID: 9784014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photopheresis therapy of cutaneous T-cell lymphoma: the Yale-New Haven Hospital experience.
    Heald PW; Perez MI; Christensen I; Dobbs N; McKiernan G; Edelson R
    Yale J Biol Med; 1989; 62(6):629-38. PubMed ID: 2534648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Documented effect of extra corporeal photopheresis on T-cell mediated diseases].
    Kofoed K; Schiødt I; Gniadecki R
    Ugeskr Laeger; 2011 Jun; 173(26):1869-74. PubMed ID: 21712008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug monitoring of orally administered 8-methoxypsoralen in patients treated with extracorporeal photopheresis.
    Balogh A; Merkel U; Looks A; Vollandt R; Wollina U
    Skin Pharmacol Appl Skin Physiol; 1998; 11(4-5):258-65. PubMed ID: 9885410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small-scale extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma: a report of 3 cases.
    Schreiner T; Gaczkowski A; Scharffetter-Kochanek K; Borberg H
    Transfus Apher Sci; 2005 Apr; 32(2):197-203. PubMed ID: 15784454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ECP versus PUVA for the treatment of cutaneous T-cell lymphoma.
    Geskin L
    Skin Therapy Lett; 2007 Jun; 12(5):1-4. PubMed ID: 17609808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flu-like syndrome, bronchoconstriction and fever caused by 5-methoxypsoralen: the first case report and literature review.
    Mantovani L; Minghetti S; Maranini C; Furicchia G; Borghi A; Virgili A
    Dermatology; 2011; 223(3):213-5. PubMed ID: 21576926
    [No Abstract]   [Full Text] [Related]  

  • 9. Photopheresis: a new therapeutic concept.
    Edelson RL
    Yale J Biol Med; 1989; 62(6):565-77. PubMed ID: 2700056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosage guidelines: extracorporeal photochemotherapy (photopheresis).
    Heald PW; Perez MI; Gasparro FP
    Arch Dermatol; 1990 Oct; 126(10):1369. PubMed ID: 2221948
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of psoralen-UV-B (311-nm) bath phototoxicity.
    Neumann NJ; Schlotmann K; Ruzicka T; Lehmann P
    Arch Dermatol; 1998 Oct; 134(10):1299-300. PubMed ID: 9801698
    [No Abstract]   [Full Text] [Related]  

  • 12. Modification of extracorporeal photopheresis technology with porphyrin precursors. Comparison between 8-methoxypsoralen and hexaminolevulinate in killing human T-cell lymphoma cell lines in vitro.
    Cunderlíková B; Vasovič V; Randeberg LL; Christensen E; Warloe T; Nesland JM; Peng Q
    Biochim Biophys Acta; 2014 Sep; 1840(9):2702-8. PubMed ID: 24915603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of cell death after treatment with extracorporeal photopheresis.
    Daniele N; Del Proposto G; Cerrone P; Sinopoli S; Sansone L; Gadaleta DI; Lanti A; Ferraro AS; Spurio S; Scerpa MC; Zinno F; Adorno G; Isacchi G
    Transfus Apher Sci; 2012 Feb; 46(1):53-7. PubMed ID: 22138605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methoxsalen with ultraviolet A therapy (PUVA).
    Rep Carcinog; 2004; 11():III165-6. PubMed ID: 21089901
    [No Abstract]   [Full Text] [Related]  

  • 15. Randomized double-blind comparative study of 8-methoxypsoralen bath plus UV-A treatment regimens.
    Berroeta L; Man I; Dawe RS; Ferguson J; Ibbotson SH
    Actas Dermosifiliogr; 2010 Oct; 101(8):729-30. PubMed ID: 20965019
    [No Abstract]   [Full Text] [Related]  

  • 16. Diffuse cutaneous mastocytosis. Treatment with oral psoralen plus UV-A.
    Mackey S; Pride HB; Tyler WB
    Arch Dermatol; 1996 Dec; 132(12):1429-30. PubMed ID: 8961869
    [No Abstract]   [Full Text] [Related]  

  • 17. Extracorporeal photochemotherapy (ECP) in children.
    Perseghin P
    Transfus Apher Sci; 2013 Apr; 48(2):161-2. PubMed ID: 23809815
    [No Abstract]   [Full Text] [Related]  

  • 18. Bath-PUVA therapy induces circulating regulatory T cells in patients with psoriasis.
    Saito C; Maeda A; Morita A
    J Dermatol Sci; 2009 Mar; 53(3):231-3. PubMed ID: 19070466
    [No Abstract]   [Full Text] [Related]  

  • 19. [Consensus document on bath-PUVA therapy. The Spanish Photobiology Group of the Spanish Academy of Dermatology and Venereology].
    Rodríguez-Granados MT; Carrascosa JM; Gárate T; Gómez-Díez S; Guimaraens-Juantorena D
    Actas Dermosifiliogr; 2007 Apr; 98(3):164-70. PubMed ID: 17504700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of plaque-type psoriasis with cream-PUVA therapy].
    Steinmeyer K; Grundmann-Kollmann M; Podda M; Kaufmann R
    Hautarzt; 2001 Oct; 52(10):885-7. PubMed ID: 17690819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.